Oral therapy shows encouraging results for early Parkinson’s disease
In a small proof-of-concept clinical trial, Biovie ’s experimental oral therapy bezisterim was associated with significantly greater improvements in motor and nonmotor symptom scores than a placebo among people with early-stage Parkinson’s disease who had higher levels of a potential inflammation ma
Source: Parkinson's News Today.